Dawn E. Smilek

3.0k total citations
38 papers, 1.5k citations indexed

About

Dawn E. Smilek is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Dawn E. Smilek has authored 38 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Immunology, 14 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Molecular Biology. Recurrent topics in Dawn E. Smilek's work include T-cell and B-cell Immunology (19 papers), Immunotherapy and Immune Responses (14 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). Dawn E. Smilek is often cited by papers focused on T-cell and B-cell Immunology (19 papers), Immunotherapy and Immune Responses (14 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). Dawn E. Smilek collaborates with scholars based in United States, United Kingdom and Canada. Dawn E. Smilek's co-authors include Lawrence Steinman, Hugh O. McDevitt, David C. Wraith, Dennis J. Mitchell, Anand M. Gautam, Cecelia I. Pearson, Gerald T. Nepom, Maria Dall’Era, Brad H. Rovin and Frédéric Houssiau and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Dawn E. Smilek

38 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dawn E. Smilek United States 19 1.1k 442 316 273 210 38 1.5k
Anne H. Cutler United States 11 1.3k 1.2× 320 0.7× 445 1.4× 188 0.7× 248 1.2× 11 1.9k
J E Salmon United States 17 1.1k 1.0× 720 1.6× 741 2.3× 395 1.4× 139 0.7× 28 2.0k
Jennifer Barnard United States 14 1.4k 1.2× 482 1.1× 731 2.3× 209 0.8× 120 0.6× 18 2.0k
Amedeo Cappione United States 14 1.5k 1.3× 494 1.1× 657 2.1× 303 1.1× 127 0.6× 21 2.1k
D Raum United States 22 1.2k 1.1× 222 0.5× 264 0.8× 287 1.1× 317 1.5× 37 1.8k
Teresa Owen United States 12 895 0.8× 288 0.7× 524 1.7× 308 1.1× 87 0.4× 14 1.5k
Susan A. Boackle United States 18 1.3k 1.2× 395 0.9× 571 1.8× 271 1.0× 72 0.3× 37 1.8k
Yoshiaki Tokano Japan 22 929 0.8× 192 0.4× 760 2.4× 207 0.8× 103 0.5× 71 1.4k
Cornelia M. Weyand United States 23 959 0.9× 468 1.1× 1.1k 3.6× 192 0.7× 70 0.3× 35 2.1k
Fanny M. Ebling United States 26 1.7k 1.6× 1.0k 2.3× 1.0k 3.3× 245 0.9× 87 0.4× 42 2.2k

Countries citing papers authored by Dawn E. Smilek

Since Specialization
Citations

This map shows the geographic impact of Dawn E. Smilek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn E. Smilek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn E. Smilek more than expected).

Fields of papers citing papers by Dawn E. Smilek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn E. Smilek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn E. Smilek. The network helps show where Dawn E. Smilek may publish in the future.

Co-authorship network of co-authors of Dawn E. Smilek

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn E. Smilek. A scholar is included among the top collaborators of Dawn E. Smilek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn E. Smilek. Dawn E. Smilek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cooney, Laura A., Qian Xiao, Jason A. Mears, et al.. (2023). 230 Immunosuppression causes dynamic changes in expression QTLs in psoriatic skin. Journal of Investigative Dermatology. 143(11). S371–S371. 1 indexed citations
2.
Xiao, Qian, Joseph Mears, Aparna Nathan, et al.. (2023). Immunosuppression causes dynamic changes in expression QTLs in psoriatic skin. Nature Communications. 14(1). 6268–6268. 8 indexed citations
3.
McKinney, Eoin, Kristina M. Harris, Dawn E. Smilek, et al.. (2021). A CD8+ NK cell transcriptomic signature associated with clinical outcome in relapsing remitting multiple sclerosis. Nature Communications. 12(1). 635–635. 38 indexed citations
4.
Huffaker, Michelle F., Srinath Sanda, Sindhu Chandran, et al.. (2021). Approaches to Establishing Tolerance in Immune Mediated Diseases. Frontiers in Immunology. 12. 744804–744804. 15 indexed citations
5.
Glatigny, Simon, Barbara Höllbacher, Samantha Motley, et al.. (2019). Abatacept Targets T Follicular Helper and Regulatory T Cells, Disrupting Molecular Pathways That Regulate Their Proliferation and Maintenance. The Journal of Immunology. 202(5). 1373–1382. 45 indexed citations
6.
Khoury, Samia J., James Rochon, Linna Ding, et al.. (2016). ACCLAIM: A randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal. 23(5). 686–695. 42 indexed citations
7.
Smilek, Dawn E. & E. William St. Clair. (2015). Solving the puzzle of autoimmunity: critical questions. F1000Prime Reports. 7. 17–17. 6 indexed citations
8.
Leadbetter, Elizabeth A., Brigitte Devaux, Geoffrey H. Sunshine, et al.. (1998). Experimental Autoimmune Encephalomyelitis Induced with a Combination of Myelin Basic Protein and Myelin Oligodendrocyte Glycoprotein Is Ameliorated by Administration of a Single Myelin Basic Protein Peptide. The Journal of Immunology. 161(1). 504–512. 33 indexed citations
9.
Pearson, Cecelia I., Dawn E. Smilek, Jayne S. Danska, & Hugh O. McDevitt. (1997). Induction of a heterogeneous TCR repertoire in (PL/JXSJL/J)F1 mice by myelin basic protein peptide Ac1-11 and its analog Ac1-11[4A]. Molecular Immunology. 34(11). 781–792. 5 indexed citations
10.
Devaux, Brigitte, et al.. (1997). Induction of EAE in mice with recombinant human MOG, and treatment of EAE with a MOG peptide. Journal of Neuroimmunology. 75(1-2). 169–173. 56 indexed citations
11.
Gautam, Anand M., Cecelia I. Pearson, Dawn E. Smilek, Lawrence Steinman, & Hugh O. McDevitt. (1992). A polyalanine peptide with only five native myelin basic protein residues induces autoimmune encephalomyelitis.. The Journal of Experimental Medicine. 176(2). 605–609. 72 indexed citations
12.
Wraith, David C., Dawn E. Smilek, & Sandra Webb. (1992). MHC-binding peptides for immunotherapy ofexperimental autoimmune disease. Journal of Autoimmunity. 5. 103–113. 23 indexed citations
13.
Smilek, Dawn E., et al.. (1991). A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis.. Proceedings of the National Academy of Sciences. 88(21). 9633–9637. 142 indexed citations
14.
Wraith, David C., Dawn E. Smilek, Dennis J. Mitchell, Lawrence Steinman, & Hugh O. McDevitt. (1990). T Cell Recognition in Experimental Autoimmune Encephalomyelitis: Prospects for Immune Intervention with Synthetic Peptides. International Reviews of Immunology. 6(1). 37–47. 8 indexed citations
15.
Smilek, Dawn E., Christopher Lock, & Hugh O. McDevitt. (1990). Antigen Recognition and Peptide‐Mediated Immunotherapy in Autoimmune Disease. Immunological Reviews. 118(1). 37–71. 24 indexed citations
16.
Wraith, David C., Dawn E. Smilek, Dennis J. Mitchell, Lawrence Steinman, & Hugh O. McDevitt. (1989). Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell. 59(2). 247–255. 346 indexed citations
17.
McDevitt, Hugh O., David C. Wraith, Dawn E. Smilek, Ante S. Lundberg, & Lawrence Steinman. (1989). Evolution, Function, and Utilization of Major Histocompatibility Complex Polymorphism in Autoimmune Disease. Cold Spring Harbor Symposia on Quantitative Biology. 54(0). 853–857. 6 indexed citations
18.
Bellgrau, Donald, Dawn E. Smilek, & Darcy B. Wilson. (1981). Induced tolerance in F1 rats to anti-major histocompatibility complex receptors on parental T cells. Implications for self tolerance.. The Journal of Experimental Medicine. 153(6). 1660–1665. 18 indexed citations
19.
Smilek, Dawn E., et al.. (1980). Monoclonal rat anti-major histocompatibility complex antibodies display specificity for rat, mouse, and human target cells.. The Journal of Experimental Medicine. 151(5). 1139–1150. 38 indexed citations
20.
McKearn, Thomas J., Frank W. Fitch, Dawn E. Smilek, M Sarmiento, & Frank P. Stuart. (1979). Properties of Rat Anti‐MHC Antibodies Produced by Cloned Rat‐Mouse Hybridomas. Immunological Reviews. 47(1). 91–115. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne H. Cutler Breakdown of academic impact, for papers by J E Salmon Breakdown of academic impact, for papers by Jennifer Barnard Breakdown of academic impact, for papers by Amedeo Cappione Breakdown of academic impact, for papers by D Raum Breakdown of academic impact, for papers by Teresa Owen Breakdown of academic impact, for papers by Susan A. Boackle Breakdown of academic impact, for papers by Yoshiaki Tokano Breakdown of academic impact, for papers by Cornelia M. Weyand Breakdown of academic impact, for papers by Fanny M. Ebling
Rankless by CCL
2026